DIA.WA
DIA.WA
PLDGNST00012
DIAG
Loading chart...

Company Profile

Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests. The company provides services to individual clients, and public and private entities. Diagnostyka S.A. was founded in 1998 and is headquartered in Kraków, Poland.

Related stocks

VIMIAN.ST
VIMIAN.ST • Sweden
Vimian Group AB
35.75 SEK
1.89B USD 1Y +21.9%
DIA.MI
DIA.MI • Italy
DIASORIN
77.42 EUR
4.27B USD 1Y -4.7%
QGEN
QGEN • Netherlands
Qiagen N.V.
45.38 USD
9.37B USD 1Y -6.8%
1QGEN.MI
1QGEN.MI • Netherlands
QIAGEN
40.1 EUR
9.28B USD 1Y +0.2%
SYNGENE.NS
SYNGENE.NS • India
SYNGENE INTERNATIONAL LTD
347.4 INR
1.44B USD 1Y -45.1%
BIM.PA
BIM.PA • France
BIOMERIEUX
83.2 EUR
11B USD 1Y -28.4%
VIJAYA.NS
VIJAYA.NS • India
VIJAYA DIAGNOSTIC CEN LTD
1,436.6 INR
1.53B USD 1Y +44.5%
300685.SZ
300685.SZ • China
AMOYDX
20.3 CNY
1.18B USD 1Y -11.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 232%.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende